Variant Gene Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs266729
rs266729
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE T2D was significantly associated with promoter rs266729, rs17300539, rs1884613, rs2144908, and rs4810424, and the association of T2D risk were affected by study population, diagnostic criteria, and genotype methods. 30860284

2019

dbSNP: rs2241766
rs2241766
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE A case-control study was conducted to assess the association of rs2241766 and rs822395 SNPs of adiponectin gene (ADIPOQ) with T2DM in Iraqi population. 29627525

2018

dbSNP: rs822395
rs822395
Diabetes Mellitus, Non-Insulin-Dependent
0.010 GeneticVariation BEFREE A case-control study was conducted to assess the association of rs2241766 and rs822395 SNPs of adiponectin gene (ADIPOQ) with T2DM in Iraqi population. 29627525

2018

dbSNP: rs17366568
rs17366568
Diabetes Mellitus, Non-Insulin-Dependent
0.010 GeneticVariation BEFREE A multi-SNP genotypic risk score for ADIPOQ alleles revealed an association with 3 independent SNPs, rs12637534, rs16861209, rs17366568 and type 2 diabetes after adjusting for adiponectin levels (OR=0.86, 95% CI=(0.75, 0.99), P=0.0134). 23351195

2013

dbSNP: rs266729
rs266729
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE A significant interaction was observed between two SNPs rs13306519 in LEPR and rs266729 in ADIPOQ for T2DM (P_int = 0.012, OR_int = 2.67) and hypertension (P_int = 0.0041, OR_int = 2.23). 24414038

2014

dbSNP: rs2241766
rs2241766
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Adiponectin rs2241766T/G and rs17300593G/A rather than rs1501299G/T and rs266729C/G polymorphisms were associated with the risk of DN in T2DM, especially in the Caucasian population. 24825737

2015

dbSNP: rs2241766
rs2241766
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Adiponectin gene polymorphism 45T>G is associated with carotid artery plaques in patients with type 2 diabetes mellitus. 18191060

2008

dbSNP: rs266729
rs266729
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Adiponectin gene polymorphism rs266729 is involved in the pathogenesis of T2DM. 26051417

2015

dbSNP: rs1501299
rs1501299
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Adiponectin rs2241766T/G and rs17300593G/A rather than rs1501299G/T and rs266729C/G polymorphisms were associated with the risk of DN in T2DM, especially in the Caucasian population. 24825737

2015

dbSNP: rs266729
rs266729
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Adiponectin rs2241766T/G and rs17300593G/A rather than rs1501299G/T and rs266729C/G polymorphisms were associated with the risk of DN in T2DM, especially in the Caucasian population. 24825737

2015

dbSNP: rs1063539
rs1063539
Diabetes Mellitus, Non-Insulin-Dependent
0.020 GeneticVariation BEFREE Among these mutations, the 4545G/C mutation (rs1063539) contributed to the genetic risk of T2D in the non-obese group (OR=2.34, 95%CI: 1.31-4.21, P=0.004), and 57% of the risk is related to this polymorphism. 19359061

2009

dbSNP: rs266729
rs266729
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Association of the ADIPOQ rs17360539 and rs266729 polymorphisms with type 2 diabetes: a meta-analysis. 20580771

2010

dbSNP: rs2241766
rs2241766
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Associations between 45T/G polymorphism of the adiponectin gene and plasma adiponectin levels with type 2 diabetes. 17973869

2007

dbSNP: rs2241766
rs2241766
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Further, the ADIPOQ g. + 45 T > G and TNF-α g. - 308 G > A polymorphisms jointly give 1.45-fold risk towards T2D. 24655058

2014

dbSNP: rs182052
rs182052
Diabetes Mellitus, Non-Insulin-Dependent
0.040 GeneticVariation BEFREE Furthermore, the synergistic interaction between β-HCH and r</span>s182052 significantly increased T2DM risk (OR <sub>I-additive model</sub> = 2.20, OR <sub>I-recessive model</sub> = 2.13). 27883041

2016

dbSNP: rs17366743
rs17366743
Diabetes Mellitus, Non-Insulin-Dependent
0.030 GeneticVariation BEFREE Gly15Gly polymorphism within the human adipocyte-specific apM-1gene but not Tyr111His polymorphism is associated with higher levels of cholesterol and LDL-cholesterol in caucasian patients with type 2 diabetes. 11571669

2001

dbSNP: rs16861194
rs16861194
Diabetes Mellitus, Non-Insulin-Dependent
0.050 GeneticVariation BEFREE However, due to the limited sample size, only the rs16861194 exerted a significant increased risk on T2DM. 29101068

2018

dbSNP: rs266729
rs266729
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE However, G vs C allele of -11377C>G (rs266729) might be a risk factor for type 2 diabetes. 21638131

2011

dbSNP: rs266729
rs266729
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE However, we found an effect modification of obesity on the association between the ADIPOQ rs266729 SNP and total cholesterol (P = 0.00068) only in obese participants after adjusting for age, gender, BMI, and T2D status. 27388775

2016

dbSNP: rs182052
rs182052
Diabetes Mellitus, Non-Insulin-Dependent
0.040 GeneticVariation BEFREE In addition, 2-site haplotype analysis in the ADIPOQ locus using only 2 marginally associated SNPs (AD/rs182052 and AD/rs7649121) revealed a significant protective association of the GA haplotype with T2D (P = .009, permutation P = .026). 19846176

2010

dbSNP: rs7649121
rs7649121
Diabetes Mellitus, Non-Insulin-Dependent
0.010 GeneticVariation BEFREE In addition, 2-site haplotype analysis in the ADIPOQ locus using only 2 marginally associated SNPs (AD/rs182052 and AD/rs7649121) revealed a significant protective association of the GA haplotype with T2D (P = .009, permutation P = .026). 19846176

2010

dbSNP: rs1501299
rs1501299
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE In conclusion, our meta-analysis suggested that the ADIPOQ rs1501299 (+276G>T) polymorphism is a low-risk factor for the development of CVDs with T2D, but the association of this polymorphism with the susceptibility to CVDs in other populations remains unknown. 22040602

2012

dbSNP: rs1063539
rs1063539
Diabetes Mellitus, Non-Insulin-Dependent
0.020 GeneticVariation BEFREE In the case-control analysis, PPARG rs1801282 (Pro12Ala) (OR=1.48 (1.02-2.16)), ADIPOQ rs1063539 (OR=1.17 (1.01-1.35)), and HNF4A rs1884614 (OR=1.16 (1.00-1.32) were associated with T2D (P(allelic)<0.05). 22515931

2012

dbSNP: rs2241766
rs2241766
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE In this case-control study, the associations of rs2241766 T/G of ADIPOQ, rs9289231 T/G of KALRN, and rs9939609 A/T of FTO polymorphisms with genetic susceptibility to CAD in type 2 diabetic (T2D) patients were investigated. 27218147

2016

dbSNP: rs1501299
rs1501299
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Interactions among moderate/severe periodontitis, rs1501299-GG, and rs1137100-GG were associated with an increased risk of T2DM. 31128439

2019